Long‐Term Safety Evaluation of Ubrogepant for the Acute Treatment of Migraine: Phase 3, Randomized, 52‐Week Extension Trial

Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition

(2018)   CEPHALALGIA

Adolescent Perspectives on the Burden of a Parent's Migraine: Results from the CaMEO Study

(2018) Dawn C. Buse et al.   HEADACHE

Migraine Burden of Disease: From the Patient's Experience to a Socio-Economic View

(2018) Reto Agosti   HEADACHE

CGRP as the target of new migraine therapies — successful translation from bench to clinic

(2018) Lars Edvinsson et al.   Nature Reviews Neurology

Targeted CGRP Small Molecule Antagonists for Acute Migraine Therapy

(2018) Philip R. Holland et al.   Neurotherapeutics

When Mom Has Migraine: An Observational Study of the Impact of Parental Migraine on Adolescent Children

(2018) Elizabeth K. Seng et al.   HEADACHE

Migraine in America Symptoms and Treatment (MAST) Study: Baseline Study Methods, Treatment Patterns, and Gender Differences

(2018) Richard B. Lipton et al.   HEADACHE

Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

(2017) Theo Vos et al.   LANCET

Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015

(2017) Valery L Feigin et al.   LANCET NEUROLOGY

A phase IIb randomized, double-blind, placebo-controlled trial of ubrogepant for the acute treatment of migraine

(2016) Tiffini Voss et al.   CEPHALALGIA

Impact of Migraine on the Family: Perspectives of People With Migraine and Their Spouse/Domestic Partner in the CaMEO Study

(2016) Dawn C. Buse et al.   MAYO CLINIC PROCEEDINGS

Randomized controlled trial of the CGRP receptor antagonist telcagepant for prevention of headache in women with perimenstrual migraine

(2015) Tony W Ho et al.   CEPHALALGIA

Drug safety in acute migraine treatment

(2015) János Tajti et al.   Expert Opinion On Drug Safety

Acute Migraine Treatment in Adults

(2015) Werner J. Becker   HEADACHE

Diagnosis, prevalence estimation and burden measurement in population surveys of headache: presenting the HARDSHIP questionnaire

(2014) Timothy J Steiner et al.   JOURNAL OF HEADACHE AND PAIN

Randomized controlled trial of the CGRP receptor antagonist telcagepant for migraine prevention

(2014) T. W. Ho et al.   NEUROLOGY

Randomized controlled trial of the CGRP receptor antagonist MK-3207 in the acute treatment of migraine

(2011) David J Hewitt et al.   CEPHALALGIA

Current practice and future directions in the prevention and acute management of migraine

(2010) Peter J Goadsby et al.   LANCET NEUROLOGY

CGRP and its receptors provide new insights into migraine pathophysiology

(2010) Tony W. Ho et al.   Nature Reviews Neurology